Bionano Q4 2025: los márgenes se disparan un 47% mientras los recortes de costes compensan la caída de ingresos
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Bionano Genomics (NASDAQ:BNGO)